{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:31:16Z","timestamp":1793035876989,"version":"4.5.0"},"reference-count":187,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["NANOTEC"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n<jats:title>ABSTRACT:<\/jats:title>\n<jats:p>Psoriasis is an inflammatory and proliferative autoimmune dermatological disorder. It is a\nskin ailment that is defined by particular, drab-red or peach-pink stiff areas with silvery scales patches.\nOther typical characteristics include the proliferation of epidermal layer, aberrant keratinization,\nhyperkeratosis, increased micro capillary vascularization, and infiltration of inflammatory mediator\nloaded cells. Conventional pharmacotherapies currently available can only provide minor advantages.\nNanomedicines based on nanotechnology can potentially improve the efficacy and safety\nof psoriasis medications. Apoptosis plays an important pathogenetic role in many chronic inflammatory\ndiseases, including those of dermatological interest, in particular, regarding psoriasis. In this regard,\ntreatments with antioxidant properties could be appropriate therapeutic options. We reviewed\nthe available studies on the efficacy of antiapoptotic therapies in psoriasis. We'll look at phytochemicals\nin this review, which are natural components found in plants with antiapoptotic activity that are\nfrequently used to treat psoriasis. For improved topical treatment, we also take into consideration the\nadvantages of loading phytoconstituents as medicines into lipid based nanocarriers. The utilization of\nherbal nanomedicines in psoriasis, as well as nano delivery carrier system for phytoconstituents with\nimproved therapeutic profiles and decreased toxicity, are the subjects of this review. The study's purpose\nis to find more effective herbal nanomedicines for treating psoriasis. In the treatment of psoriasis,\nphytoconstituents that have shown antipsoriatic potential in recent years, as well as phytoconstituents\nloaded based nanomedicines, have a lot of promising roles to be explored. Furthermore, very\nfew patents have been found in the field of nanotechnology utilizing lipid-based nanocarrier system\nfor the treatment of psoriasis. Therefore, this review greatly compels the researcher to validate the\nprocess development of lipid-based drug delivery system for the patentability of the product. This\nshould be in a view of shifting in the applicability of the drug delivery system for general public\nhealth as a potential treatment option in psoriasis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1872210517666230201103935","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T04:02:40Z","timestamp":1675310560000},"page":"220-236","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of Apoptotic-targeted Phytoconstitutent-loaded Antipsoriatic\nNanobiocomposites"],"prefix":"10.2174","volume":"18","author":[{"given":"Pankaj","family":"Singh  Patel","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Moradabad Educational Trust Group of Institutions, Moradabad, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Panchawat","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1111\/bjd.15610","volume":"177","author":"Griffiths C.E.M.","year":"2017","unstructured":"Griffiths C.E.M.; van der Walt J.M.; Ashcroft D.M.; The global state of psoriasis disease epidemiology: A workshop report. Br J Dermatol  2017,177(1),e4-e7","journal-title":"Br J Dermatol"},{"key":"ref=2","year":"2016","unstructured":"Global Report on Psoriasis Genova: World Health Organization World Health Organization Available from:  https:\/\/apps.who.int\/iris\/handle\/10665\/2044172016","journal-title":"Global Report on Psoriasis Genova: World Health Organization"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1468-3083.2012.04531.x","volume":"27","author":"Lima X.T.","year":"2013","unstructured":"Lima X.T.; Minnillo R.; Spencer J.M.; Kimball A.B.; Psoriasis prevalence among the 2009 aad national melanoma\/skin cancer screening program participants. J Eur Acad Dermatol Venereol  2013,27(6),680-685","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jad.2019.10.043","volume":"262","author":"Min C.","year":"2020","unstructured":"Min C.; Kim M.; Oh D.J.; Choi H.G.; Bidirectional association between psoriasis and depression: Two longitudinal follow-up studies using a national sample cohort. J Affect Disord  2020,262,126-132","journal-title":"J Affect Disord"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/children6120133","volume":"6","author":"Na C.H.","year":"2019","unstructured":"Na C.H.; Chung J.; Simpson E.L.; Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Children  2019,6(12),133","journal-title":"Children"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3109\/21691401.2013.837474","volume":"42","author":"Parnami N.","year":"2014","unstructured":"Parnami N.; Garg T.; Rath G.; Goyal A.K.; Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol  2014,42(6),406-412","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jdermsci.2011.11.007","volume":"65","author":"Mabuchi T.","year":"2012","unstructured":"Mabuchi T.; Chang T.W.; Quinter S.; Hwang S.T.; Chemokine receptors in the pathogenesis and therapy of psoriasis. J Dermatol Sci  2012,65(1),4-11","journal-title":"J Dermatol Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1055\/a-0582-9372","volume":"68","author":"Ahmad U.","year":"2018","unstructured":"Ahmad U.; Ahmad Z.; Khan A.; Akhtar J.; Singh S.; Ahmad F.; Strategies in development and delivery of nanotechnology based cosmetic products. Drug Res  2018,68(10),545-552","journal-title":"Drug Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5897\/AJPP2022.5292","volume":"16","author":"Yosita K.","year":"2022","unstructured":"Yosita K.; Wanna C.; Kesara N.B.; Herbal medicine for psoriasis and their molecular targets: A systematic review. Afr J Pharm Pharmacol  2022,16(3),27-52","journal-title":"Afr J Pharm Pharmacol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2174\/187153012802002901","volume":"12","author":"Rahman M.","year":"2012","unstructured":"Rahman M.; Alam K.; Ahmad M.Z.; Classical to current approach for treatment of psoriasis: A review. Endocr Metab Immune Disord Drug Targets  2012,12(3),287-302","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"109128","DOI":"10.1016\/j.biopha.2019.109128","volume":"117","author":"Ma Z.","year":"2019","unstructured":"Ma Z.; Zhang B.; Fan Y.; Traditional chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases. Biomed Pharmacother  2019,117,109128","journal-title":"Biomed Pharmacother"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.biopha.2018.07.156","volume":"107","author":"Pradhan M.","year":"2018","unstructured":"Pradhan M.; Alexander A.; Singh M.R.; Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother  2018,107,447-463","journal-title":"Biomed Pharmacother"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ejps.2017.02.030","volume":"101","author":"Abdelgawad R.","year":"2017","unstructured":"Abdelgawad R.; Nasr M.; Moftah N.H.; Hamza M.Y.; Phospholipid membrane tubulation using ceramide doping &#x201C;Cerosomes&#x201D;: Characterization and clinical application in psoriasis treatment. Eur J Pharm Sci  2017,101,258-268","journal-title":"Eur J Pharm Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"103961","DOI":"10.1016\/j.mvr.2019.103961","volume":"128","author":"&#xD6;zt&#xFC;rk A.A","year":"2020","unstructured":"&#xD6;zt&#xFC;rk A.A; K\u0131yan HT. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay. Microvasc Res  2020,128,103961","journal-title":"Microvasc Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jid.2018.09.037","volume":"139","author":"Itoh T.","year":"2019","unstructured":"Itoh T.; Hatano R.; Komiya E.; Biological effects of il-26 on t cell\u2013mediated skin inflammation, including psoriasis. J Invest Dermatol  2019,139(4),878-889","journal-title":"J Invest Dermatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12016-017-8634-3","volume":"55","author":"Boehncke W.H.","year":"2018","unstructured":"Boehncke W.H.; Brembilla N.C.; Unmet needs in the field of psoriasis: Pathogenesis and treatment. Clin Rev Allergy Immunol  2018,55(3),295-311","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"Lowes M.A.","year":"2014","unstructured":"Lowes M.A.; Su&#xE1;rez-Fari&#xF1;as M.; Krueger J.G.; Immunology of psoriasis. Annu Rev Immunol  2014,32(1),227-255","journal-title":"Annu Rev Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1038\/jid.2010.165","volume":"130","author":"Fuentes-Duculan J.","year":"2010","unstructured":"Fuentes-Duculan J.; Su&#xE1;rez-Fari&#xF1;as M.; Zaba L.C.; A subpopulation of CD163-positive macrophages is classically activated in psoriasis. J Invest Dermatol  2010,130(10),2412-2422","journal-title":"J Invest Dermatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.5021\/ad.2016.28.4.451","volume":"28","author":"Song H.S.","year":"2016","unstructured":"Song H.S.; Kim S.J.; Park T.I.; Jang Y.H.; Lee E.S.; Immunohistochemical comparison of il-36 and the il-23\/th17 axis of generalized pustular psoriasis and acute generalized exanthematous pustulosis. Ann Dermatol  2016,28(4),451-456","journal-title":"Ann Dermatol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/ijms19010179","volume":"19","author":"Chiricozzi A.","year":"2018","unstructured":"Chiricozzi A.; Romanelli P.; Volpe E.; Borsellino G.; Romanelli M.; Scanning the immunopathogenesis of psoriasis. Int J Mol Sci  2018,19(1),179","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"108294","DOI":"10.1016\/j.clim.2019.108294","volume":"210","author":"Han G.","year":"2020","unstructured":"Han G.; Havnaer A.; Lee H.H.; Carmichael D.J.; Martinez L.R.; Biological depletion of neutrophils attenuates pro-inflammatory markers and the development of the psoriatic phenotype in a murine model of psoriasis. Clin Immunol  2020,210,108294","journal-title":"Clin Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.jid.2019.11.022","volume":"140","author":"Zhu Z.","year":"2020","unstructured":"Zhu Z.; Chen J.; Lin Y.; Aryl hydrocarbon receptor in cutaneous vascular endothelial cells restricts psoriasis development by negatively regulating neutrophil recruitment. J Invest Dermatol  2020,140(6),1233-1243.e9","journal-title":"J Invest Dermatol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00403-012-1230-8","volume":"304","author":"Gabr S.A.","year":"2012","unstructured":"Gabr S.A.; Al-Ghadir A.H.; Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis. Arch Dermatol Res  2012,304(6),451-457","journal-title":"Arch Dermatol Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/exd.14565","volume":"31","author":"Cheng C.","year":"2022","unstructured":"Cheng C.; Yang Z.; Yin X.; Huang S.; Yan J.; Sun Q.; CircEIF5 contributes to hyperproliferation and inflammation of keratinocytes in psoriasis via p\u2010NF&#x3BA;B and p\u2010STAT3 signaling pathway. Exp Dermatol  2022,31(8),1145-1153","journal-title":"Exp Dermatol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ajps.2022.02.003","volume":"17","author":"Chen R.","year":"2022","unstructured":"Chen R.; Zhai Y.Y.; Sun L.; Alantolactone-loaded chitosan\/hyaluronic acid nanoparticles suppress psoriasis by deactivating stat3 pathway and restricting immune cell recruitment. Asian J Pharm Sci  2022,17(2),268-283","journal-title":"Asian J Pharm Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1038\/jid.2015.82","volume":"135","author":"Xie S.","year":"2015","unstructured":"Xie S.; Su Z.; Zhang B.; SIRT1 activation ameliorates aldara-induced psoriasiform phenotype and histology in mice. J Invest Dermatol  2015,135(7),1915-1918","journal-title":"J Invest Dermatol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2165\/11533240-000000000-00000","volume":"11","author":"Bovenschen H.J.","year":"2010","unstructured":"Bovenschen H.J.; Langewouters A.M.G.; van de Kerkhof P.C.M.; Dimethylfumarate for psoriasis. Am J Clin Dermatol  2010,11(5),343-350","journal-title":"Am J Clin Dermatol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/283634","volume":"2015","author":"Antiga E.","year":"2015","unstructured":"Antiga E.; Bonciolini V.; Volpi W.; Del Bianco E.; Caproni M.; Oral curcumin (meriva) is effective as an adjuvant treatment and is able to reduce il-22 serum levels in patients with psoriasis vulgaris. BioMed Res Int  2015,2015,1-7","journal-title":"BioMed Res Int"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/ijd.12565","volume":"54","author":"Gnanaraj P.","year":"2015","unstructured":"Gnanaraj P.; Dayalan H.; Elango T.; Malligarjunan H.; Raghavan V.; Rao R.; Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: Immunohistochemistry and gene expression analysis. Int J Dermatol  2015,54(3),302-306","journal-title":"Int J Dermatol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.jaci.2018.11.042","volume":"143","author":"Visvanathan S.","year":"2019","unstructured":"Visvanathan S.; Baum P.; Vinisko R.; Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab. J Allergy Clin Immunol  2019,143(6),2158-2169","journal-title":"J Allergy Clin Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jaad.2019.02.062","volume":"81","author":"Ortiz-Salvador J.M.","year":"2019","unstructured":"Ortiz-Salvador J.M.; Saneleuterio-Temporal M.; Magdaleno-Tapial J.; A prospective multicenter study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients. J Am Acad Dermatol  2019,81(2),427-432","journal-title":"J Am Acad Dermatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","volume":"4","author":"Sies H.","year":"2015","unstructured":"Sies H.; Oxidative stress: A concept in redox biology and medicine. Redox Biol  2015,4,180-183","journal-title":"Redox Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ceb.2014.09.010","volume":"33","author":"Reczek C.R.","year":"2015","unstructured":"Reczek C.R.; Chandel N.S.; ROS-dependent signal transduction. Curr Opin Cell Biol  2015,33,8-13","journal-title":"Curr Opin Cell Biol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jash.2014.07.002","volume":"8","author":"Harrison D.G.","year":"2014","unstructured":"Harrison D.G.; Basic science. J Am Soc Hypertens  2014,8(8),601-603","journal-title":"J Am Soc Hypertens"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1556\/650.2016.30589","volume":"157","author":"P&#xE9;ter I.","year":"2016","unstructured":"P&#xE9;ter I.; Jagicza A.; Ajtay Z.; Kiss I.; N&#xE9;meth B.; Psoriasis and oxidative stress. Hungarian  2016,157(45),1781-1785","journal-title":"Hungarian"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1179\/1351000213Y.0000000045","volume":"18","author":"Barygina V.V.","year":"2013","unstructured":"Barygina V.V.; Becatti M.; Soldi G.; Altered redox status in the blood of psoriatic patients: Involvement of NADPH oxidase and role of anti-TNF-&#x3B1; therapy. Redox Rep  2013,18(3),100-106","journal-title":"Redox Rep"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/ijms19061572","volume":"19","author":"Becatti M.","year":"2018","unstructured":"Becatti M.; Barygina V.; Mannucci A.; Sirt1 protects against oxidative stress-induced apoptosis in fibroblasts from psoriatic patients: A new insight into the pathogenetic mechanisms of psoriasis. Int J Mol Sci  2018,19(6),1572","journal-title":"Int J Mol Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3109\/10715762.2016.1162301","volume":"50","author":"Lin X.","year":"2016","unstructured":"Lin X.; Huang T.; Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radic Res  2016,50(6),585-595","journal-title":"Free Radic Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/13510002.2018.1462027","volume":"23","author":"Lai R.","year":"2018","unstructured":"Lai R.; Xian D.; Xiong X.; Yang L.; Song J.; Zhong J.; Proanthocyanidins: Novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells. Redox Rep  2018,23(1),130-135","journal-title":"Redox Rep"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/cbf.3011","volume":"32","author":"Houshang N.","year":"2014","unstructured":"Houshang N.; Reza K.; Masoud S.; Ali E.; Mansour R.; Vaisi-Raygani A.; Antioxidant status in patients with psoriasis. Cell Biochem Funct  2014,32(3),268-273","journal-title":"Cell Biochem Funct"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/med.21330","volume":"35","author":"Lei Y.","year":"2015","unstructured":"Lei Y.; Wang K.; Deng L.; Chen Y.; Nice E.C.; Huang C.; Redox regulation of inflammation: Old elements, a new story. Med Res Rev  2015,35(2),306-340","journal-title":"Med Res Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/ijms20030739","volume":"20","author":"Georgescu S.R.","year":"2019","unstructured":"Georgescu S.R.; Tampa M.; Caruntu C.; Advances in understanding the immunological pathways in psoriasis. Int J Mol Sci  2019,20(3),739","journal-title":"Int J Mol Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ad.2016.12.001","volume":"108","author":"Richarz N.A.","year":"2017","unstructured":"Richarz N.A.; Boada A.; Carrascosa J.M.; Insights of molecular mechanisms and latest developments. Actas Dermosifiliogr  2017,108(6),515-523","journal-title":"Actas Dermosifiliogr"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.4049\/jimmunol.175.9.6177","volume":"175","author":"Numasaki M.","year":"2005","unstructured":"Numasaki M.; Watanabe M.; Suzuki T.; IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol  2005,175(9),6177-6189","journal-title":"J Immunol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1179\/1351000213Y.0000000046","volume":"18","author":"Murdaca G.","year":"2013","unstructured":"Murdaca G.; Span&#xF2; F.; Cagnati P.; Puppo F.; Free radicals and endothelial dysfunction: Potential positive effects of TNF-&#x3B1; inhibitors. Redox Rep  2013,18(3),95-99","journal-title":"Redox Rep"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2012.05.013","volume":"224","author":"Murdaca G.","year":"2012","unstructured":"Murdaca G.; Colombo B.M.; Cagnati P.; Gulli R.; Span&#xF2; F.; Puppo F.; Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis  2012,224(2),309-317","journal-title":"Atherosclerosis"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000477417","volume":"30","author":"Garcia-Peterson L.M.","year":"2017","unstructured":"Garcia-Peterson L.M.; Wilking-Busch M.J.; Ndiaye M.A.; Philippe C.G.A.; Setaluri V.; Ahmad N.; Sirtuins in skin and skin cancers. Skin Pharmacol Physiol  2017,30(4),216-224","journal-title":"Skin Pharmacol Physiol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00403-013-1320-2","volume":"305","author":"Serravallo M.","year":"2013","unstructured":"Serravallo M.; Jagdeo J.; Glick S.A.; Siegel D.M.; Brody N.I.; Sirtuins in dermatology: Applications for future research and therapeutics. Arch Dermatol Res  2013,305(4),269-282","journal-title":"Arch Dermatol Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8167273","volume":"2016","author":"Vachharajani V.T.","year":"2016","unstructured":"Vachharajani V.T.; Liu T.; Wang X.; Hoth J.J.; Yoza B.K.; McCall C.E.; Sirtuins Link Inflammation and Metabolism. J Immunol Res  2016,2016,1-10","journal-title":"J Immunol Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3892\/ijmm.2018.3623","volume":"42","author":"Zhou M.","year":"2018","unstructured":"Zhou M.; Luo J.; Zhang H.; Role of sirtuin 1 in the pathogenesis of ocular disease (Review). Int J Mol Med  2018,42(1),13-20","journal-title":"Int J Mol Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/ars.2017.7290","volume":"28","author":"Singh C.K.","year":"2018","unstructured":"Singh C.K.; Chhabra G.; Ndiaye M.A.; Garcia-Peterson L.M.; Mack N.J.; Ahmad N.; The role of sirtuins in antioxidant and redox signaling. Antioxid Redox Signal  2018,28(8),643-661","journal-title":"Antioxid Redox Signal"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/jid.2008.179","volume":"129","author":"Blander G.","year":"2009","unstructured":"Blander G.; Bhimavarapu A.; Mammone T.; SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol  2009,129(1),41-49","journal-title":"J Invest Dermatol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jdermsci.2014.03.004","volume":"75","author":"Wu Z.","year":"2014","unstructured":"Wu Z.; Uchi H.; Morino-Koga S.; Shi W.; Furue M.; Resveratrol inhibition of human keratinocyte proliferation via SIRT1\/ARNT\/ERK dependent downregulation of aquaporin 3. J Dermatol Sci  2014,75(1),16-23","journal-title":"J Dermatol Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1002\/jcb.27936","volume":"120","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Huo J.; Zhang D.; Hu G.; Zhang Y.; Chemerin\/ChemR23 axis triggers an inflammatory response in keratinocytes through ROS\u2010sirt1\u2010NF\u2010&#x3BA;B signaling. J Cell Biochem  2019,120(4),6459-6470","journal-title":"J Cell Biochem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3892\/ijmm.2019.4173","volume":"44","author":"Fan X.","year":"2019","unstructured":"Fan X.; Yan K.; Meng Q.; Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7. Int J Mol Med  2019,44(1),157-171","journal-title":"Int J Mol Med"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8506195","volume":"2019","author":"Yan T.","year":"2019","unstructured":"Yan T.; Huang J.; Nisar M.F.; Wan C.; Huang W.; The beneficial roles of sirt1 in drug-induced liver injury. Oxid Med Cell Longev  2019,2019,1-14","journal-title":"Oxid Med Cell Longev"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1152\/physrev.00028.2011","volume":"92","author":"Kyriakis J.M.","year":"2012","unstructured":"Kyriakis J.M.; Avruch J.; Mammalian MAPK signal transduction pathways activated by stress and inflammation: A 10-year update. Physiol Rev  2012,92(2),689-737","journal-title":"Physiol Rev"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.fct.2013.02.038","volume":"61","author":"Corsini E.","year":"2013","unstructured":"Corsini E.; Galbiati V.; Nikitovic D.; Tsatsakis A.M.; Role of oxidative stress in chemical allergens induced skin cells activation. Food Chem Toxicol  2013,61,74-81","journal-title":"Food Chem Toxicol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/5584_2014_98","volume":"849","author":"Koren Carmi I.","year":"2014","unstructured":"Koren Carmi I.; Haj R.; Yehuda H.; Tamir S.; Reznick A.Z.; The role of oxidation in FSL-1 induced signaling pathways of an atopic dermatitis model in HaCaT keratinocytes. Adv Exp Med Biol  2014,849,1-10","journal-title":"Adv Exp Med Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/exd.13865","volume":"28","author":"Bak D.H.","year":"2019","unstructured":"Bak D.H.; Lee E.; Lee B.C.; Therapeutic potential of topically administered &#x3B3;-AlOOH on 2,4-dinitrochlorobenzene-induced atopic dermatitis-like lesions in Balb\/c mice. Exp Dermatol  2019,28(2),169-176","journal-title":"Exp Dermatol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"phpp.12456","DOI":"10.1111\/phpp.12456","volume":"35","author":"Ko&#xE7;t&#xFC;rk S","year":"2019","unstructured":"Ko&#xE7;t&#xFC;rk S; Y&#xFC;ksel Egrilmez M; Aktan &#x15E;; et al. Melatonin attenuates the detrimental effects of UVA irradiation in human dermal fibroblasts by suppressing oxidative damage and MAPK \/ AP \u20101 signal pathway in vitro. Photodermatol Photoimmunol Photomed  2019,35(4),phpp.12456","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.yexmp.2007.05.002","volume":"83","author":"Yu X.J.","year":"2007","unstructured":"Yu X.J.; Li C.Y.; Dai H.Y.; Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol  2007,83(3),413-418","journal-title":"Exp Mol Pathol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2133.2004.06304.x","volume":"152","author":"Johansen C.","year":"2005","unstructured":"Johansen C.; Kragballe K.; Westergaard M.; Henningsen J.; Kristiansen K.; Iversen L.; The mitogen-activated protein kinases p38 and ERK1\/2 are increased in lesional psoriatic skin. Br J Dermatol  2005,152(1),37-42","journal-title":"Br J Dermatol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0923-1811(02)00064-6","volume":"30","author":"Takahashi H.","year":"2002","unstructured":"Takahashi H.; Ibe M.; Nakamura S.; Ishida-Yamamoto A.; Hashimoto Y.; Iizuka H.; Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. J Dermatol Sci  2002,30(2),94-99","journal-title":"J Dermatol Sci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/jid.2013.535","volume":"134","author":"Schumacher M.","year":"2014","unstructured":"Schumacher M.; Schuster C.; Rogon Z.M.; Efficient keratinocyte differentiation strictly depends on JNK-induced soluble factors in fibroblasts. J Invest Dermatol  2014,134(5),1332-1341","journal-title":"J Invest Dermatol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3892\/mmr.2018.9024","volume":"18","author":"Yang B.","year":"2018","unstructured":"Yang B.; Xu B.; Zhao H.; Dioscin protects against coronary heart disease by reducing oxidative stress and inflammation via Sirt1\/Nrf2 and p38 MAPK pathways. Mol Med Rep  2018,18(1),973-980","journal-title":"Mol Med Rep"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.3892\/mmr.2018.8482","volume":"17","author":"Gu X.","year":"2018","unstructured":"Gu X.; Cai Z.; Cai M.; AMPK\/SIRT1\/p38 MAPK signaling pathway regulates alcohol induced neurodegeneration by resveratrol. Mol Med Rep  2018,17(4),5402-5408","journal-title":"Mol Med Rep"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/hepr.12563","volume":"46","author":"Wang T.","year":"2016","unstructured":"Wang T.; Takikawa Y.; Carnosic acid protects normal mouse hepatocytes against H2O2 \u2010induced cytotoxicity via sirtuin 1\u2010mediated signaling. Hepatol Res  2016,46(2),239-246","journal-title":"Hepatol Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"e0142081","DOI":"10.1371\/journal.pone.0142081","volume":"10","author":"Krueger J.G.","year":"2015","unstructured":"Krueger J.G.; Su&#xE1;rez-Fari&#xF1;as M.; Cueto I.; A randomized, placebo-controlled study of srt2104, a sirt1 activator, in patients with moderate to severe psoriasis. PLoS One  2015,10(11),e0142081","journal-title":"PLoS One"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41598-019-38778-2","volume":"9","author":"Nguyen T.T.","year":"2019","unstructured":"Nguyen T.T.; Ung T.T.; Li S.; Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-&#x3BA;B activity. Sci Rep  2019,9(1),2003","journal-title":"Sci Rep"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","volume":"69","author":"Goldminz AM","year":"2013","unstructured":"Goldminz AM; Au SC; Kim N; Gottlieb AB; Lizzul PF; NF-&#x3BA;B: An essential transcription factor in psoriasis. J Dermatol Sci  2013,69(2),89-94","journal-title":"J Dermatol Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"7454","DOI":"10.1038\/ncomms8454","volume":"6","author":"Hara-Chikuma M.","year":"2015","unstructured":"Hara-Chikuma M.; Satooka H.; Watanabe S.; Aquaporin-3-mediated hydrogen peroxide transport is required for NF-&#x3BA;B signalling in keratinocytes and development of psoriasis. Nat Commun  2015,6(1),7454","journal-title":"Nat Commun"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1600-0560.2007.00841.x","volume":"35","author":"Abdou A.G.","year":"2008","unstructured":"Abdou A.G.; Hanout H.M.; Evaluation of survivin and NF-&#x3BA;B in psoriasis, an immunohistochemical study. J Cutan Pathol  2008,35(5),445-451","journal-title":"J Cutan Pathol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"e46364","DOI":"10.1371\/journal.pone.0046364","volume":"7","author":"Yang H.","year":"2012","unstructured":"Yang H.; Zhang W.; Pan H.; SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-&#x3BA;B activity. PLoS One  2012,7(9),e46364","journal-title":"PLoS One"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","volume":"25","author":"Kauppinen A.","year":"2013","unstructured":"Kauppinen A.; Suuronen T.; Ojala J.; Kaarniranta K.; Salminen A.; Antagonistic crosstalk between NF-&#x3BA;B and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal  2013,25(10),1939-1948","journal-title":"Cell Signal"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.05.016","volume":"50","author":"Sano S.","year":"2008","unstructured":"Sano S.; Chan K.S.; DiGiovanni J.; Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases. J Dermatol Sci  2008,50(1),1-14","journal-title":"J Dermatol Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.freeradbiomed.2009.06.033","volume":"47","author":"Zhou Q.","year":"2009","unstructured":"Zhou Q.; Mrowietz U.; Rostami-Yazdi M.; Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med  2009,47(7),891-905","journal-title":"Free Radic Biol Med"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","volume":"1171","author":"Aggarwal B.B.","year":"2009","unstructured":"Aggarwal B.B.; Kunnumakkara A.B.; Harikumar K.B.; Signal transducer and activator of transcription-3, inflammation, and cancer: How intimate is the relationship? Ann N Y Acad Sci  2009,1171(1),59-76","journal-title":"Ann N Y Acad Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/ijms19010171","volume":"19","author":"Calautti E.","year":"2018","unstructured":"Calautti E.; Avalle L.; Poli V.; Psoriasis: A STAT3-Centric View. Int J Mol Sci  2018,19(1),171","journal-title":"Int J Mol Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"21132","DOI":"10.1038\/srep21132","volume":"6","author":"Zhang B.","year":"2016","unstructured":"Zhang B.; Xie S.; Su Z.; Heme oxygenase-1 induction attenuates imiquimod-induced psoriasiform inflammation by negative regulation of Stat3 signaling. Sci Rep  2016,6(1),21132","journal-title":"Sci Rep"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1096\/fj.10-172288","volume":"25","author":"Sestito R.","year":"2011","unstructured":"Sestito R.; Madonna S.; Scarponi C.; STAT3\u2010dependent effects of IL\u201022 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J  2011,25(3),916-927","journal-title":"FASEB J"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/21655979.2020.1863015","volume":"12","author":"Liu A.","year":"2021","unstructured":"Liu A.; Zhang B.; Zhao W.; Tu Y.; Wang Q.; Li J.; Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-&#x3BA;B and MAPKs signaling pathways. Bioengineered  2021,12(1),183-195","journal-title":"Bioengineered"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/bjd.17852","volume":"181","author":"Shi H.J.","year":"2019","unstructured":"Shi H.J.; Zhou H.; Ma A.L.; Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis. Br J Dermatol  2019,181(5),1028-1037","journal-title":"Br J Dermatol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1365-2133.2011.10689.x","volume":"166","author":"Kokolakis G.","year":"2012","unstructured":"Kokolakis G.; Giannikaki E.; Stathopoulos E.; Avramidis G.; Tosca A.D.; Kr&#xFC;ger-Krasagakis S.; Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions. Br J Dermatol  2012,166(3),491-497","journal-title":"Br J Dermatol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.intimp.2019.05.042","volume":"73","author":"Yu Q.","year":"2019","unstructured":"Yu Q.; Tong Y.; Cui L.; Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis. Int Immunopharmacol  2019,73,442-450","journal-title":"Int Immunopharmacol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10238-016-0431-4","volume":"17","author":"Elango T.","year":"2017","unstructured":"Elango T.; Thirupathi A.; Subramanian S.; Ethiraj P.; Dayalan H.; Gnanaraj P.; Methotrexate treatment provokes apoptosis of proliferating keratinocyte in psoriasis patients. Clin Exp Med  2017,17(3),371-381","journal-title":"Clin Exp Med"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5114\/ada.2018.77767","volume":"37","author":"Aksoy M.","year":"2020","unstructured":"Aksoy M.; Kirmit A.; Thiol\/disulphide balance in patients with psoriasis. Postepy Dermatol Alergol  2020,37(1),52-55","journal-title":"Postepy Dermatol Alergol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-981-15-3449-2_8","volume":"1253","author":"Shao S.","year":"2020","unstructured":"Shao S.; Gudjonsson J.E.; Epigenetics of psoriasis. Adv Exp Med Biol  2020,1253,209-221","journal-title":"Adv Exp Med Biol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"619","DOI":"10.5114\/dr.2017.71834","volume":"104","author":"Baran A.","year":"2017","unstructured":"Baran A.; Kiluk P.; My&#x15B;liwiec H, Flisiak I. The role of lipids in psoriasis. Przegl Dermatol  2017,104(6),619-635","journal-title":"Przegl Dermatol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ceca.2016.04.002","volume":"60","author":"Magenta A.","year":"2016","unstructured":"Magenta A.; Dellambra E.; Ciarapica R.; Capogrossi M.C.; Oxidative stress, microRNAs and cytosolic calcium homeostasis. Cell Calcium  2016,60(3),207-217","journal-title":"Cell Calcium"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","volume":"7","author":"Perera G.K.","year":"2012","unstructured":"Perera G.K.; Di Meglio P.; Nestle F.O.; Psoriasis. Annu Rev Pathol  2012,7(1),385-422","journal-title":"Annu Rev Pathol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3886:AID-IMMU3886>3.0.CO;2-M","volume":"28","author":"Verhasselt V.","year":"1998","unstructured":"Verhasselt V.; Goldman M.; Willems F.; Oxidative stress up-regulates IL-8 and TNF-&#x3B1; synthesis by human dendritic cells. Eur J Immunol  1998,28(11),3886-3890","journal-title":"Eur J Immunol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0891-5849(98)00194-4","volume":"26","author":"Rutault K.","year":"1999","unstructured":"Rutault K.; Alderman C.; Chain B.M.; Katz D.R.; Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med  1999,26(1-2),232-238","journal-title":"Free Radic Biol Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1099\/jmm.0.003939-0","volume":"58","author":"Jain S.","year":"2009","unstructured":"Jain S.; Kaur I.R.; Das S.; Bhattacharya S.N.; Singh A.; T helper 1 to T helper 2 shift in cytokine expression: An autoregulatory process in superantigen-associated psoriasis progression? J Med Microbiol  2009,58(2),180-184","journal-title":"J Med Microbiol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1179\/1351000213Y.0000000044","volume":"18","author":"Gostner J.M.","year":"2013","unstructured":"Gostner J.M.; Becker K.; Fuchs D.; Sucher R.; Redox regulation of the immune response. Redox Rep  2013,18(3),88-94","journal-title":"Redox Rep"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/039463200902200214","volume":"22","author":"Campanati A.","year":"2009","unstructured":"Campanati A.; Goteri G.; Simonetti O.; Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation. Int J Immunopathol Pharmacol  2009,22(2),371-377","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1468-3083.2009.03181.x","volume":"23","author":"Nofal A.","year":"2009","unstructured":"Nofal A.; Al-Makhzangy I.; Attwa E.; Nassar A.; Abdalmoati A.; Vascular endothelial growth factor in psoriasis: An indicator of disease severity and control. J Eur Acad Dermatol Venereol  2009,23(7),803-806","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2011.04.007","volume":"63","author":"Armstrong A.W.","year":"2011","unstructured":"Armstrong A.W.; Voyles S.V.; Armstrong E.J.; Fuller E.N.; Rutledge J.C.; Angiogenesis and oxidative stress: Common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci  2011,63(1),1-9","journal-title":"J Dermatol Sci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1080\/09546634.2016.1254331","volume":"28","author":"Svendsen M.T.","year":"2017","unstructured":"Svendsen M.T.; Jeyabalan J.; Andersen K.E.; Andersen F.; Johannessen H.; Worldwide utilization of topical remedies in treatment of psoriasis: A systematic review. J Dermatolog Treat  2017,28(5),374-383","journal-title":"J Dermatolog Treat"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/ptr.6032","volume":"32","author":"Lee S.Y.","year":"2018","unstructured":"Lee S.Y.; Nam S.; Hong I.K.; Kim H.; Yang H.; Cho H.J.; Antiproliferation of keratinocytes and alleviation of psoriasis by the ethanol extract of Artemisia capillaris. Phytother Res  2018,32(5),923-932","journal-title":"Phytother Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3610494","volume":"2018","author":"Lee S.Y.","year":"2018","unstructured":"Lee S.Y.; Nam S.; Kim S.; Therapeutic efficacies of Artemisia capillaris extract cream formulation in imiquimod-induced psoriasis models. Evid Based Complement Alternat Med  2018,2018,1-8","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4103\/pm.pm_218_19","volume":"16","author":"Yan X.","year":"2020","unstructured":"Yan X.; Zhang H.; Dang M.; Chen X.; Rehmannia radix extract ameliorates imiquimod-induced psoriasis-like skin inflammation in a mouse model via the janus-kinase signal transducer and activator of transcription pathway. Pharmacogn Mag  2020,16(71),613","journal-title":"Pharmacogn Mag"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"172881","DOI":"10.1016\/j.ejphar.2019.172881","volume":"868","author":"Jia J.","year":"2020","unstructured":"Jia J.; Mo X.; Liu J.; Mechanism of danshensu-induced inhibition of abnormal epidermal proliferation in psoriasis. Eur J Pharmacol  2020,868,172881","journal-title":"Eur J Pharmacol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/exd.13511","volume":"27","author":"Tang L.","year":"2018","unstructured":"Tang L.; He S.; Wang X.; Cryptotanshinone reduces psoriatic epidermal hyperplasia via inhibiting the activation of STAT3. Exp Dermatol  2018,27(3),268-275","journal-title":"Exp Dermatol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7807313","volume":"2017","author":"Lai C.Y.","year":"2017","unstructured":"Lai C.Y.; Su Y.W.; Lin K.I.; Hsu L.C.; Chuang T.H.; Natural modulators of endosomal toll-like receptor-mediated psoriatic skin inflammation. J Immunol Res  2017,2017,1-15","journal-title":"J Immunol Res"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/nu9121306","volume":"9","author":"Oliveira A.","year":"2017","unstructured":"Oliveira A.; Monteiro V.; Navegantes-Lima K.; Resveratrol role in autoimmune disease-A mini-review. Nutrients  2017,9(12),1306","journal-title":"Nutrients"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1016\/j.ejmech.2010.08.059","volume":"45","author":"Putic A.","year":"2010","unstructured":"Putic A.; Stecher L.; Prinz H.; M&#xFC;ller K.; Structure\u2013activity relationship studies of acridones as potential antipsoriatic agents. 2. Synthesis and antiproliferative activity of 10-substituted hydroxy-10H-acridin-9-ones against human keratinocyte growth. Eur J Med Chem  2010,45(11),5345-5352","journal-title":"Eur J Med Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1159\/000373955","volume":"35","author":"Xiong H.","year":"2015","unstructured":"Xiong H.; Xu Y.; Tan G.; Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice and inhibits TNF-&#x3B1;-induced ICAM-1 expression via NF-&#x3BA;B\/MAPK in HaCaT cells. Cell Physiol Biochem  2015,35(4),1335-1346","journal-title":"Cell Physiol Biochem"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/ar2682","volume":"11","author":"Kang H.K.","year":"2009","unstructured":"Kang H.K.; Ecklund D.; Liu M.; Datta S.K.; Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis Res Ther  2009,11(2),R59","journal-title":"Arthritis Res Ther"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"e0192297","DOI":"10.1371\/journal.pone.0192297","volume":"13","author":"Smoli\u0144ska E","year":"2018","unstructured":"Smoli\u0144ska E; Moskot M; Jak&#xF3;bkiewicz-Banecka J; et al. Molecular action of isoflavone genistein in the human epithelial cell line Ha-CaT. PLoS One  2018,13(2),e0192297","journal-title":"PLoS One"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12906-019-2535-3","volume":"19","author":"Deenonpoe R.","year":"2019","unstructured":"Deenonpoe R.; Prayong P.; Thippamom N.; Meephansan J.; Na-Bangchang K.; Anti-inflammatory effect of naringin and sericin combination on human peripheral blood mononuclear cells (hPBMCs) from patient with psoriasis. BMC Complement Altern Med  2019,19(1),168","journal-title":"BMC Complement Altern Med"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12906-016-1325-4","volume":"16","author":"Zhang S.","year":"2016","unstructured":"Zhang S.; Liu X.; Mei L.; Wang H.; Fang F.; Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB\/c mice. BMC Complement Altern Med  2016,16(1),334","journal-title":"BMC Complement Altern Med"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9416962","volume":"2020","author":"Nguyen U.T.","year":"2020","unstructured":"Nguyen U.T.; Nguyen L.T.H.; Kim B.A.; Choi M.J.; Yang I.J.; Shin H.M.; Natural compound mixture, containing emodin, genipin, chlorogenic acid, cimigenoside, and ginsenoside rb1, ameliorates psoriasis-like skin lesions by suppressing inflammation and proliferation in keratinocytes. Evid Based Complement Alternat Med  2020,2020,1-13","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/792840","volume":"2013","author":"Mok C.F.","year":"2013","unstructured":"Mok C.F.; Xie C.M.; Sham K.W.Y.; Lin Z.X.; Cheng C.H.K.; 1,4-dihydroxy-2-naphthoic acid induces apoptosis in human keratinocyte: potential application for psoriasis treatment. Evid Based Complement Alternat Med  2013,2013,1-19","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ejphar.2011.09.014","volume":"670","author":"Zhou L.L.","year":"2011","unstructured":"Zhou L.L.; Lin Z.X.; Fung K.P.; Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-&#x3BA;B activity. Eur J Pharmacol  2011,670(2-3),399-408","journal-title":"Eur J Pharmacol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/molecules22020299","volume":"22","author":"Yu S.","year":"2017","unstructured":"Yu S.; Yan H.; Zhang L.; A review on the phytochemistry, pharmacology, and pharmacokinetics of amentoflavone, a naturally-occurring biflavonoid. Molecules  2017,22(2),299","journal-title":"Molecules"},{"key":"ref=117","first-page":"663","volume":"20","author":"Tse W.P.","year":"2007","unstructured":"Tse W.P.; Cheng C.H.; Che C.T.; Zhao M.; Lin Z.X.; Induction of apoptosis underlies the Radix Rubiae-mediated anti-proliferative action on human epidermal keratinocytes: Implications for psoriasis treatment. Int J Mol Med  2007,20(5),663-672","journal-title":"Int J Mol Med"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/1099-1573(200102)15:1<76:AID-PTR747>3.0.CO;2-O","volume":"15","author":"Rihn B.","year":"2001","unstructured":"Rihn B.; Saliou C.; Bottin M.C.; Keith G.; Packer L.; From ancient remedies to modern therapeutics: Pine bark uses in skin disorders revisited. Phytother Res  2001,15(1),76-78","journal-title":"Phytother Res"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jep.2010.08.030","volume":"132","author":"Garc&#xED;a-P&#xE9;rez M.E.","year":"2010","unstructured":"Garc&#xED;a-P&#xE9;rez M.E.; Royer M.; Duque-Fernandez A.; Diouf P.N.; Stevanovic T.; Pouliot R.; Antioxidant, toxicological and antiproliferative properties of Canadian polyphenolic extracts on normal and psoriatic keratinocytes. J Ethnopharmacol  2010,132(1),251-258","journal-title":"J Ethnopharmacol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3892\/or.2015.3950","volume":"34","author":"Song X.","year":"2015","unstructured":"Song X.; Li Y.; Zhang H.; Yang Q.; The anticancer effect of Huaier (Review). Oncol Rep  2015,34(1),12-21","journal-title":"Oncol Rep"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2372895","volume":"2018","author":"Su D.","year":"2018","unstructured":"Su D.; Zhang X.; Zhang L.; Zhou J.; Zhang F.; A randomized, double-blind, controlled clinical study on the curative effect of huaier on mild-to-moderate psoriasis and an experimental study on the proliferation of hacat cells. BioMed Res Int  2018,2018,1-9","journal-title":"BioMed Res Int"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/1871523016666170720160037","volume":"16","author":"Shraibom N.","year":"2017","unstructured":"Shraibom N.; Madaan A.; Joshi V.; Evaluation of in vitro anti-psoriatic activity of a novel polyherbal formulation by multiparametric analysis. Antiinflamm Antiallergy Agents Med Chem  2017,16(2),94-111","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.2042-7158.2011.01383.x","volume":"64","author":"Gasparetto J.C.","year":"2012","unstructured":"Gasparetto J.C.; Martins C.A.F.; Hayashi S.S.; Otuky M.F.; Pontarolo R.; Ethnobotanical and scientific aspects of Malva sylvestris L.: A millennial herbal medicine. J Pharm Pharmacol  2012,64(2),172-189","journal-title":"J Pharm Pharmacol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/ics.12399","volume":"39","author":"Moore D.J.","year":"2017","unstructured":"Moore D.J.; Rawlings A.V.; The chemistry, function and (patho)physiology of stratum corneum barrier ceramides. Int J Cosmet Sci  2017,39(4),366-372","journal-title":"Int J Cosmet Sci"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1515\/afpuc-2017-0004","volume":"64","author":"V\u2019avrov\u2019a K.A.","year":"2017","unstructured":"V\u2019avrov\u2019a K.A.; Kov\u2019a&#x2C7;cik and L. Op\u2019alka, Ceramides in the skin barier. Eur Pharm J  2017,64,28-35","journal-title":"Eur Pharm J"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00894-019-4008-5","volume":"25","author":"Badhe Y.","year":"2019","unstructured":"Badhe Y.; Gupta R.; Rai B.; Structural and barrier properties of the skin ceramide lipid bilayer: A molecular dynamics simulation study. J Mol Model  2019,25(5),140","journal-title":"J Mol Model"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2174\/1381612825666190404121507","volume":"25","author":"Arriagada F.","year":"2019","unstructured":"Arriagada F.; Morales J.; Limitations and opportunities in topical drug delivery: Interaction between silica nanoparticles and skin barrier. Curr Pharm Des  2019,25(4),455-466","journal-title":"Curr Pharm Des"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"9693","DOI":"10.1021\/acsnano.8b03800","volume":"12","author":"Jiang T.","year":"2018","unstructured":"Jiang T.; Wang T.; Li T.; Enhanced transdermal drug delivery by transfersome-embedded oligopeptide hydrogel for topical chemotherapy of melanoma. ACS Nano  2018,12(10),9693-9701","journal-title":"ACS Nano"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.2217\/nnm-2019-0345","volume":"14","author":"Tiwari N.","year":"2019","unstructured":"Tiwari N.; Sonzogni A.S.; Calder&#xF3;n M.; Can dermal delivery of therapeutics be improved using thermoresponsive nanogels? Nanomedicine (Lond)  2019,14(22),2891-2895","journal-title":"Nanomedicine (Lond)"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/B978-0-12-824390-9.00017-7","author":"Yadav K.","year":"2022","unstructured":"Yadav K.; Pradhan M.; Singh D.; Singh M.R.;  Translational Autoimmunity  2022,361-393","journal-title":"Translational Autoimmunity"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.cclet.2018.10.037","volume":"29","author":"Zhou X.","year":"2018","unstructured":"Zhou X.; Hao Y.; Yuan L.; Nano-formulations for transdermal drug delivery: A review. Chin Chem Lett  2018,29(12),1713-1724","journal-title":"Chin Chem Lett"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jddst.2019.05.041","volume":"52","author":"Ali A.","year":"2019","unstructured":"Ali A.; Ali S.; Aqil M.; Imam S.S.; Ahad A.; Qadir A.; Thymoquinone loaded dermal lipid nano particles: Box Behnken design optimization to preclinical psoriasis assessment. J Drug Deliv Sci Technol  2019,52,713-721","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.2147\/IJN.S215153","volume":"14","author":"Kang J.H.","year":"2019","unstructured":"Kang J.H.; Chon J.; Kim Y.I.; Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution. Int J Nanomedicine  2019,14,5381-5396","journal-title":"Int J Nanomedicine"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"100257","DOI":"10.1016\/j.phyplu.2022.100257","volume":"14","author":"Wadhwa K.","year":"2022","unstructured":"Wadhwa K.; Kadian V.; Puri V.; New insights into quercetin nanoformulations for topical delivery. Phytomedicine Plus  2022,14,100257","journal-title":"Phytomedicine Plus"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.ijbiomac.2018.08.136","volume":"120","author":"Tripathi P","year":"2018","unstructured":"Tripathi P; Kumar A; Jain PK; Patel JR; Carbomer gel bearing methotrexate loaded lipid nanocontainers shows improved topical delivery intended for effective management of psoriasis. Int J Biol Macromol  2018,120(Pt A),1322-1334","journal-title":"Int J Biol Macromol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jamadermatol.2016.0859","volume":"152","author":"Kumar R.","year":"2016","unstructured":"Kumar R.; Dogra S.; Amarji B.; Efficacy of novel topical liposomal formulation of cyclosporine in mild to moderate stable plaque psoriasis. JAMA Dermatol  2016,152(7),807-815","journal-title":"JAMA Dermatol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ejps.2016.10.025","volume":"96","author":"Doppalapudi S.","year":"2017","unstructured":"Doppalapudi S.; Jain A.; Chopra D.K.; Khan W.; Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. Eur J Pharm Sci  2017,96,515-529","journal-title":"Eur J Pharm Sci"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/08982104.2020.1748646","volume":"31","author":"Chen J.","year":"2021","unstructured":"Chen J.; Ma Y.; Tao Y.; Formulation and evaluation of a topical liposomal gel containing a combination of zedoary turmeric oil and tretinoin for psoriasis activity. J Liposome Res  2021,31(2),130-144","journal-title":"J Liposome Res"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.msec.2016.07.043","volume":"69","author":"Moghddam S.R.M.","year":"2016","unstructured":"Moghddam S.R.M.; Ahad A.; Aqil M.; Imam S.S.; Sultana Y.; Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis. Mater Sci Eng C  2016,69,789-797","journal-title":"Mater Sci Eng C"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2147\/IJN.S156412","volume":"13","author":"Abu Hashim I.","year":"2018","unstructured":"Abu Hashim I.; Abo El-Magd N.; El-Sheakh A.; Hamed M.; Abd El-Gawad A.E.G.; Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo\u2013in vivo evaluation study. Int J Nanomedicine  2018,13,1059-1079","journal-title":"Int J Nanomedicine"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4172\/0975-0851.1000385","volume":"10","author":"Parkash V.","year":"2018","unstructured":"Parkash V.; Maan S.; Chaudhary V.; Jogpal V.; Mittal G.; Jain V.; Implementation of design of experiments in development and optimization of transfersomal carrier system of tacrolimus for the dermal management of psoriasis in albino wistar rat. J Bioequivalence Bioavailab  2018,10(5),98-105","journal-title":"J Bioequivalence Bioavailab"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/pharmaceutics12050446","volume":"12","author":"Fathalla D.","year":"2020","unstructured":"Fathalla D.; Youssef E.M.K.; Soliman G.M.; Liposomal and ethosomal gels for the topical delivery of anthralin: Preparation, comparative evaluation and clinical assessment in psoriatic patients. Pharmaceutics  2020,12(5),446","journal-title":"Pharmaceutics"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.2147\/IJN.S125302","volume":"12","author":"Musa S.H.","year":"2017","unstructured":"Musa S.H.; Basri M.; Fard Masoumi H.R.; Shamsudin N.; Salim N.; Enhancement of physicochemical properties of nanocolloidal carrier loaded with cyclosporine for topical treatment of psoriasis: in vitro diffusion and in vivo hydrating action. Int J Nanomedicine  2017,12,2427-2441","journal-title":"Int J Nanomedicine"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/pharmaceutics14020383","volume":"14","author":"Nair A.B.","year":"2022","unstructured":"Nair A.B.; Kumar S.; Dalal P.; Novel dermal delivery cargos of clobetasol propionate: An update. Pharmaceutics  2022,14(2),383","journal-title":"Pharmaceutics"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jddst.2018.12.020","volume":"49","author":"Rajitha P.","year":"2019","unstructured":"Rajitha P.; Shammika P.; Aiswarya S.; Gopikrishnan A.; Jayakumar R.; Sabitha M.; Chaulmoogra oil based methotrexate loaded topical nanoemulsion for the treatment of psoriasis. J Drug Deliv Sci Technol  2019,49,463-476","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"101847","DOI":"10.1016\/j.jddst.2020.101847","volume":"59","author":"Algahtani M.S.","year":"2020","unstructured":"Algahtani M.S.; Ahmad M.Z.; Ahmad J.; Nanoemulsion loaded polymeric hydrogel for topical delivery of curcumin in psoriasis. J Drug Deliv Sci Technol  2020,59,101847","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=147","author":"Bagchi D.","year":"2020","unstructured":"Bagchi D.; Das A.; Roy S.;  Wound healing, tissue repair and regeneration in diabetes  2020","journal-title":"Wound healing, tissue repair and regeneration in diabetes"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJN.S52634","volume":"9","author":"Silva P.","year":"2013","unstructured":"Silva P.; Bonif&#xE1;cio B.; Ramos M.; Negri K.; Maria Bauab T.; Chorilli M.; Nanotechnology-based drug delivery systems and herbal medicines: a review. Int J Nanomedicine  2013,9,1-15","journal-title":"Int J Nanomedicine"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2147\/IJN.S38378","volume":"9","author":"Onoue S.","year":"2014","unstructured":"Onoue S.; Yamada S.; Chan K.; Nanodrugs: Pharmacokinetics and safety. Int J Nanomedicine  2014,9,1025-1037","journal-title":"Int J Nanomedicine"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/2231-4040.101006","volume":"3","author":"Ansari S.H.","year":"2012","unstructured":"Ansari S.H.; Sameem M.; Islam F.; Influence of nanotechnology on herbal drugs: A Review. J Adv Pharm Technol Res  2012,3(3),142-146","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1021\/np100550t","volume":"74","author":"Kingston D.G.I.","year":"2011","unstructured":"Kingston D.G.I.; Modern natural products drug discovery and its relevance to biodiversity conservation. J Nat Prod  2011,74(3),496-511","journal-title":"J Nat Prod"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jconrel.2014.06.005","volume":"193","author":"Kaur I.P.","year":"2014","unstructured":"Kaur I.P.; Kakkar V.; Deol P.K.; Yadav M.; Singh M.; Sharma I.; Issues and concerns in nanotech product development and its commercialization. J Control Release  2014,193,51-62","journal-title":"J Control Release"},{"key":"ref=153","first-page":"5729","volume":"9","author":"Khorasani A.A.","year":"2014","unstructured":"Khorasani A.A.; Weaver J.L.; Salvador-Morales C.; Closing the gap: accelerating the translational process in nanomedicine by proposing standardized characterization techniques. Int J Nanomedicine  2014,9,5729-5751","journal-title":"Int J Nanomedicine"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jconrel.2012.10.007","volume":"164","author":"Wei A.","year":"2012","unstructured":"Wei A.; Mehtala J.G.; Patri A.K.; Challenges and opportunities in the advancement of nanomedicines. J Control Release  2012,164(2),236-246","journal-title":"J Control Release"},{"key":"ref=155","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4172\/2161-0444.1000312","volume":"5","author":"Patel S.","year":"2015","unstructured":"Patel S.; Nanda R.; Sahoo S.; Nanotechnology in healthcare: Applications and challenges. Med Chem  2015,5(21),528-533","journal-title":"Med Chem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S2221-1691(13)60060-X","volume":"3","author":"Kesarwani K.","year":"2013","unstructured":"Kesarwani K.; Gupta R.; Mukerjee A.; Bioavailability enhancers of herbal origin: An overview. Asian Pac J Trop Biomed  2013,3(4),253-266","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/2212711906666190723144111","volume":"6","author":"Gilani S.J.","year":"2020","unstructured":"Gilani S.J.; Beg S.; Kala C.; Chemically nano-engineered theranostics for phytoconstituents as healthcare application. Curr Biochem Eng  2020,6(1),53-61","journal-title":"Curr Biochem Eng"},{"key":"ref=158","first-page":"89","author":"Rai V.K.","year":"2020","unstructured":"Rai V.K.; Gupta G.D.; Pottoo F.H.; Barkat M.;  Potential of nano-structured drug delivery system for phytomedicine delivery Nanophytomedicine  2020,89-111","journal-title":"Potential of nano-structured drug delivery system for phytomedicine delivery Nanophytomedicine"},{"key":"ref=159","first-page":"33","author":"Shukla R.","year":"2020","unstructured":"Shukla R.; Kakade S.; Handa M.; Kohli K.;  Emergence of nanophytomedicine in health care setting Nanophytomedicine  2020,33-53","journal-title":"Emergence of nanophytomedicine in health care setting Nanophytomedicine"},{"key":"ref=160","first-page":"S171","volume":"11","author":"Tapadiya G.G.","year":"2017","unstructured":"Tapadiya G.G.; Kale M.A.; Saboo S.S.; Impact of nanotechnology on global trade of herbal drugs: An overview. International Journal of Green Pharmacy  2017,11(3),S171","journal-title":"International Journal of Green Pharmacy"},{"key":"ref=161","doi-asserted-by":"publisher","DOI":"10.32474\/ANOAJ.2018.01.000103","volume":"1","author":"Snehal B.","year":"2018","unstructured":"Snehal B.; Application of nanotechnology for phyto constituents: Review. Arch Nano Op Acc J  2018,1(1)","journal-title":"Arch Nano Op Acc J"},{"key":"ref=162","year":"2020","unstructured":"Diterpenoid compound, preparation method and application thereof, and pharmaceutically acceptable derivative, pharmaceutical composition and application of diterpenoid compound.  Available from:  https:\/\/patents.google.com\/patent\/CN113788787A\/en?q=antipsoriasisandbefore=priority:20220829andafter=priority:201912312020"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"102614","DOI":"10.1016\/j.jaut.2021.102614","volume":"118","author":"Srivastava A.K.","year":"2021","unstructured":"Srivastava A.K.; Chand Yadav T.; Khera H.K.; Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities. J Autoimmun  2021,118,102614","journal-title":"J Autoimmun"},{"key":"ref=164","year":"2022","unstructured":"Use of zyz-802 in preparation of drug for treating psoriasis.  Available from:  https:\/\/patents.google.com\/patent\/WO2022048214A1\/en?q=((patents+(antipsoriasis))+OR+(treatment+of+psoriasis)+OR+(bio+nanocomposite+to+treat+psoriasis))andbefore=priority:20220829andafter=priority:201912312022"},{"key":"ref=165","year":"2022","unstructured":"Glycyrrhetinic acid-modified curcumin-loaded multifunctional\nethosome as well as preparation method and application thereof.\nCN111617039B Available from: https:\/\/patents.google.com\/patent\/CN111617039B\/en?q=antipsoriasisandbefore=priority:20220829andafter=priority:20191231 2022"},{"key":"ref=166","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s13346-021-01031-3","volume":"12","author":"Zhao Z.","year":"2022","unstructured":"Zhao Z.; Liu T.; Zhu S.; Natural medicine combined with nanobased topical delivery systems: A new strategy to treat psoriasis. Drug Deliv Transl Res  2022,12(6),1326-1338","journal-title":"Drug Deliv Transl Res"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/13510002.2019.1658377","volume":"24","author":"Xu F.","year":"2019","unstructured":"Xu F.; Xu J.; Xiong X.; Deng Y.; Salidroside inhibits MAPK, NF-&#x3BA;B, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation. Redox Rep  2019,24(1),70-74","journal-title":"Redox Rep"},{"key":"ref=168","year":"2020","unstructured":"Antipsoriatic cosmetic composition in a gel form. Patent RU2742411C1  Available from:  https:\/\/patents.google.com\/patent\/RU2742411C1\/en?q=antipsoriasisandbefore=priority:20220829andafter=priority:201912312020","journal-title":"Patent RU2742411C1"},{"key":"ref=169","year":"2020","unstructured":"Nano drug delivery system with mimic enzyme activity, drugloaded nanoparticles, and preparation method and application thereof.  Available from:  https:\/\/patents.google.com\/patent\/CN111467503A\/en?q=antipsoriasisandbefore=priority:20220829andafter=priority:201912312020"},{"key":"ref=170","year":"2022","unstructured":"Method for evaluating the antipsoriatic effect of an external agent on a laboratory model of imiquimod-induced psoriasis.  Available from:  https:\/\/patents.google.com\/patent\/RU2764549C1\/en?q=antipsoriasisandbefore=priority:20220829andafter=priority:201912312022"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"e922035","DOI":"10.12659\/MSM.922035","volume":"26","author":"Krawczyk A.","year":"2020","unstructured":"Krawczyk A.; Mi&#x15B;kiewicz J, Strzelec K, Wcis\u0142o-Dziadecka D, Strzalka-Mrozik B. Apoptosis in autoimmunological diseases, with particular consideration of molecular aspects of psoriasis. Med Sci Monit  2020,26,e922035","journal-title":"Med Sci Monit"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/molecules27030591","volume":"27","author":"Nowak-Perlak M.","year":"2022","unstructured":"Nowak-Perlak M.; Szpadel K.; Jab\u0142o\u0144ska I, Pizon M, Wo&#x17A;niak M. Promising strategies in plant-derived treatments of psoriasis-update of in vitro, in vivo, and clinical trials studies. Molecules  2022,27(3),591","journal-title":"Molecules"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.3390\/ijms20102558","volume":"20","author":"Huang T.H.","year":"2019","unstructured":"Huang T.H.; Lin C.F.; Alalaiwe A.; Yang S.C.; Fang J.Y.; Apoptotic or antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis. Int J Mol Sci  2019,20(10),2558","journal-title":"Int J Mol Sci"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"29080","DOI":"10.1039\/D1RA06087B","volume":"11","author":"Mohd N.U.U.","year":"2021","unstructured":"Mohd N.U.U.; Ahmad N.; Salim N.; Mohd Y.N.S.; Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects. RSC Advances  2021,11(46),29080-29101","journal-title":"RSC Advances"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/2468187310999201022192318","volume":"11","author":"Yadav N.","year":"2021","unstructured":"Yadav N.; Aggarwal R.; Targhotra M.; Sahoo P.K.; Chauhan M.K.; Natural and nanotechnology based treatment: An alternative approach to psoriasis. Curr Nanomed  2021,11(1),21-39","journal-title":"Curr Nanomed"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"102663","DOI":"10.1016\/j.jddst.2021.102663","volume":"64","author":"Khan A.","year":"2021","unstructured":"Khan A.; Qadir A.; Ali F.; Aqil M.; Phytoconstituents based nanomedicines for the management of psoriasis. J Drug Deliv Sci Technol  2021,64,102663","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=177","first-page":"6055","volume":"10","author":"Watkins R.","year":"2015","unstructured":"Watkins R.; Wu L.; Zhang C.; Davis R.M.; Xu B.; Natural product-based nanomedicine: recent advances and issues. Int J Nanomedicine  2015,10,6055-6074","journal-title":"Int J Nanomedicine"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1055\/s-0043-102949","volume":"83","author":"Bilia A.","year":"2017","unstructured":"Bilia A.; Piazzini V.; Guccione C.; Improving on nature: the role of nanomedicine in the development of clinical natural drugs. Planta Med  2017,83(5),366-381","journal-title":"Planta Med"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/B978-0-12-819666-3.00018-3","author":"Karpuz M.","year":"2020","unstructured":"Karpuz M.; Gunay M.S.; Ozer A.Y.;  Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents  2020,525-553","journal-title":"Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/02652048.2019.1612475","volume":"36","author":"Kumar S.","year":"2019","unstructured":"Kumar S.; Singh K.K.; Rao R.; Enhanced anti-psoriatic efficacy and regulation of oxidative stress of a novel topical babchi oil (Psoralea corylifolia) cyclodextrin-based nanogel in a mouse tail model. J Microencapsul  2019,36(2),140-155","journal-title":"J Microencapsul"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/21691401.2013.832683","volume":"43","author":"Agrawal U.","year":"2015","unstructured":"Agrawal U.; Gupta M.; Vyas S.P.; Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis. Artif Cells Nanomed Biotechnol  2015,43(1),33-39","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=182","first-page":"825","volume":"44","author":"Gupta R.","year":"2016","unstructured":"Gupta R.; Gupta M.; Mangal S.; Agrawal U.; Vyas S.P.; Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy. Artif Cells Nanomed Biotechnol  2016,44(3),825-834","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12906-019-2675-5","volume":"19","author":"Negi P.","year":"2019","unstructured":"Negi P.; Sharma I.; Hemrajani C.; Thymoquinone-loaded lipid vesicles: a promising nanomedicine for psoriasis. BMC Complement Altern Med  2019,19(1),334","journal-title":"BMC Complement Altern Med"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/j.jddst.2020.101775","volume":"57","author":"Qadir A.","year":"2020","unstructured":"Qadir A.; Aqil M.; Ali A.; Nanostructured lipidic carriers for dual drug delivery in the management of psoriasis: Systematic optimization, dermatokinetic and preclinical evaluation. J Drug Deliv Sci Technol  2020,57,101775","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.2217\/nnm-2018-0135","volume":"13","author":"Sahu S.","year":"2018","unstructured":"Sahu S.; Katiyar S.S.; Kushwah V.; Jain S.; Active natural oil-based nanoemulsion containing tacrolimus for synergistic antipsoriatic efficacy. Nanomedicine (Lond)  2018,13(16),1985-1998","journal-title":"Nanomedicine (Lond)"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7150\/thno.29715","volume":"9","author":"Zhang Y.","year":"2019","unstructured":"Zhang Y.; Xia Q.; Li Y.; CD44 assists the topical anti-psoriatic efficacy of curcumin-loaded hyaluronan-modified ethosomes: A new strategy for clustering drug in inflammatory skin. Theranostics  2019,9(1),48-64","journal-title":"Theranostics"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40199-020-00352-x","volume":"28","author":"Iriventi P.","year":"2020","unstructured":"Iriventi P.; Gupta N.V.; Osmani R.A.M.; Balamuralidhara V.; Design and development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis. Daru  2020,28(2),489-506","journal-title":"Daru"}],"container-title":["Recent Patents on Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1872210517666230201103935","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/213334\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1872210517666230201103935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T17:16:09Z","timestamp":1713374169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/213334\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":187,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1872210517666230201103935","relation":{},"ISSN":["1872-2105"],"issn-type":[{"value":"1872-2105","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}